Why it matters
The guidance concerns software connected to prescription drug use, an area relevant to patients, drug makers and health technology companies in the United States. Its practical effect cannot be assessed from the supplied summary.
HEALTH POLICY & CARE • UNITED STATES
FDA finalizes guidance on software related to prescription drug use
This brief summarizes public reporting and official announcements. Research findings may be preliminary. Talk to a qualified clinician before making health decisions.
This event has left the current brief. The summary below describes the stored record; open the original sources for current conditions.
BLUF
STAT reports that the FDA has finalized guidance on software related to prescription drug use. The supplied article summary does not explain what the guidance says or how it changes requirements.
HOW THIS BRIEF WAS MADE 1 outlet: 1 specialist. Automated sourcing and summaries by the BLUF engine. Corrections